Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Can-Fite BioPharma completed enrollment of the first 247 patients, triggering the pre-specified interim analysis of its pivotal Phase 3 trial (NCT06643260) for piclidenoson, a first-in-class oral A3 adenosine receptor (A3AR) agonist, in moderate-to-severe plaque psoriasis
A splice variant, GHS-R1b, is truncated and has not been shown to signal in response to these ligands
Considering the functions of GLP-1, its exendin-4 analogue is used in the treatment of type 2 diabetes [26]
Hadidchi emphasizes the importance of communication and scheduling follow-ups to track your comfort and progress
US$ 22.92
US$ 20.65
US$ 29.78
US$ 26.24
US$ 24.23
US$ 25.89
US$ 29.46
US$ 24.07
US$ 29.15
US$ 26.99
US$ 21.78
